4D Molecular Therapeutics, Inc.
FDMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57 | -$55 | -$48 | -$50 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $0 | $7 | $0 |
| Change in WC | $5 | $6 | -$7 | -$4 |
| Other Non-Cash | -$1 | $4 | -$1 | $6 |
| Operating Cash Flow | -$46 | -$43 | -$48 | -$46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$115 | -$134 | -$58 |
| Inv. Sales/Matur. | $33 | $102 | $167 | $66 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $18 | -$14 | $32 | $7 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $1 | $0 | $1 |
| Forex Effect | $0 | -$7 | $0 | $0 |
| Net Chg. in Cash | -$29 | -$64 | -$16 | -$38 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77 | $134 | $149 | $188 |
| End Cash | $49 | $70 | $134 | $149 |
| Free Cash Flow | -$46 | -$43 | -$48 | -$47 |